• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Poll results: What pipeline presbyopia treatment are you most looking forward to?

Article

See our latest poll results

Optometry Times® polled our audience with the following question from October 22, 2021 to November 5, 2021:​ What pipeline presbyopia treatment are you most looking forward to?

The poll appeared on optometrytimes.com and was promoted on various social media channels. Results show the presbyopia treatment ODs are most looking forward to is Visus Therapeutics Brimochol.

81 ODs responded, in total. Of these:

  • 1 responded "Orasis CSF-1"
  • 5 responded "Allergan AGN-190584 drop"
  • 3 responded "Eyenovia MicroLine drop"
  • 1 responded "Presbyopia Therapies PRX-100"
  • 2 responded "Ocuphire Pharma Nyxol"
  • 69 responded "Visus Therapeutics Brimochol"

Click here to take our latest poll: Where are you focusing your efforts in Q4?

Related Videos
Jacob R. Lang, OD, FAAO
Easy Anyama
The ins and outs of fitting multifocal contact lenses with Dr Jessica Crooker
Brianna Rhue, OD, FAAO
© 2024 MJH Life Sciences

All rights reserved.